3 citations
,
July 2024 in “Journal of Clinical Medicine” This study found that alopecia areata patients have a higher prevalence of carotid subclinical atherosclerosis, with factors such as disease duration, systemic inflammation, and insulin resistance potentially contributing to this increased risk.
3 citations
,
January 2023 in “Indian Dermatology Online Journal” This study reported a series of mild to moderate cutaneous adverse drug reactions following COVID-19 vaccination, predominantly after Covishield, with only one requiring hospitalization.
3 citations
,
August 2022 in “International Journal of Molecular Sciences” This review discusses the increased incidence of hair loss and telogen effluvium among COVID-19 patients and evaluates existing evidence for regenerative treatments like PRP and HFSCs, finding limited published data.
3 citations
,
February 2020 in “International Journal of Research in Dermatology” According to this source, dermaroller therapy is increasingly used in dermatology for conditions like acne scars and melasma due to its cost-effectiveness, minimal adverse effects, and ability to enhance topical treatment absorption, making it a popular resurfacing option across all skin types.
3 citations
,
February 2020 in “The Egyptian Rheumatologist” This case report from Tishreen Hospital describes the rare presentation of lupus erythematosus tumidus and autoimmune thyroid dysfunction as initial manifestations of systemic lupus erythematosus, highlighting the importance of early diagnosis for better outcomes.
3 citations
,
February 2018 in “Clinical Medical Reviews and Case Reports” In this report, a rare case of scalp arteriovenous fistula following hair transplantation was successfully treated using direct puncture embolization with n-butyl cyanoacrylate glue, demonstrating effective management of this condition.
2 citations
,
July 2023 in “Life” This study reports that telogen effluvium, a reversible hair loss condition following COVID-19, is influenced by factors like stress and inflammation, but appropriate dermatological treatment can aid recovery, as highlighted by a clinical case example.
2 citations
,
March 2023 in “Experimental neurology” In this study, pregnenolone was found to dose-dependently reduce L-DOPA-induced dyskinesias in a rat model of Parkinson's disease, suggesting its potential as a therapeutic target for these dyskinesias.
2 citations
,
March 2022 in “PubMed” In this study, 19.6% of COVID-19 vaccine recipients reported post-vaccination mucocutaneous effects, mostly mild and self-limiting; the reactions were similarly frequent for Covishield and Covaxin.
1 citations
,
September 2025 in “Journal of Zhejiang University SCIENCE B” This abstract outlines the current understanding of cutaneous squamous cell carcinoma (cSCC), identifying it as the second most common non-melanoma skin cancer with risk factors like UV exposure and immunosuppression. It highlights cSCC's potential to metastasize and become fatal, affecting 2%-5% of in situ cases.
1 citations
,
August 2025 in “Seeds” This review examines the potential of Cucurbitaceae seeds, such as those from watermelon, melon, and pumpkin, as sustainable and innovative ingredients in cosmetics, highlighting their rich bioactive composition and benefits for skin and hair, despite challenges like environmental instability and low permeability.
1 citations
,
May 2025 in “BMC Cancer” In this study, the researchers found that different CDK4/6 inhibitors used in treating HR+/HER2- advanced breast cancer have varying safety profiles and impacts on patient quality of life.
1 citations
,
March 2024 in “Pathogens” The systematic review reports an association between Beau’s lines and COVID-19 infection or vaccination, observing variability in onset and resolution times, and suggesting these nail disorders might indicate previous severe infection or vaccination, as well as potentially signify long COVID-19 syndrome.
1 citations
,
October 2023 in “Animals” This study found that supplementing raccoon dogs' diets with 0.25 g/kg Platycladus orientalis leaf extract improved growth performance and altered intestinal microbiota, but higher doses may have adverse effects.
1 citations
,
July 2023 in “Biomimetics” This study found that a hair-coating polyphenol complex significantly enhanced the mechanical strength, UV protection, and antistatic properties of damaged hair, suggesting potential benefits for hair treatment.
1 citations
,
January 2023 in “Chemical Engineering Journal”
1 citations
,
December 2022 in “Pharmaceuticals” This study found that a sub-fraction of Noni fruit, FEA-3, showed hair growth-promoting effects in a rabbit model of androgenic alopecia, similar to Minoxidil.
1 citations
,
November 2022 in “Anais Brasileiros de Dermatologia” This study found that hospitalized pediatric COVID-19 patients frequently display skin, mucosal, and nail manifestations, particularly periorbital erythema and edema, and the authors suggest COVID-19 be considered among childhood viral exanthem rashes.
1 citations
,
November 2022 in “F1000Research” This study observed that the COVID-19 pandemic altered the pattern of dermatoses among Iraqi females, with significant increases in hair loss and decreases in viral skin infections.
1 citations
,
November 2022 in “Aaps Pharmscitech”
1 citations
,
October 2022 in “Current Dermatology Reports” This review discusses various skin reactions after SARS-CoV-2 infection and COVID-19 vaccination, noting a higher incidence with mRNA vaccines than adenovirus vector vaccines, and reports no new clinical results.
1 citations
,
August 2022 in “Piel” This study found a statistically significant association between dermatological manifestations with vasculonecrotic damage and increased probability of severe COVID-19 disease among patients in Guatemala.
1 citations
,
January 2022 in “Turkiye Klinikleri Journal of Dermatology” This study observed shifts in dermatological disease frequencies amid early COVID-19 pandemic lifestyle changes, noting significant increases in urticaria, drug eruptions, and alopecia areata, while bacterial and fungal infections decreased.
1 citations
,
November 2021 in “F1000Research” This study observed that during the COVID-19 pandemic, Iraqi females experienced significantly increased hair loss, while contagious viral infections decreased in a dermatology clinic setting.
1 citations
,
August 2020 in “Open Access Macedonian Journal of Medical Sciences” This review summarizes current knowledge on cutaneous symptoms in COVID-19, emphasizing their potential prognostic and therapeutic implications, but reports no new clinical findings.
1 citations
,
December 2019 in “Current Medicinal Chemistry” This study found that anti-androgens may reduce OCD symptoms, but the evidence is of low quality and further large, randomized trials are needed.
July 2026 in “Pharmaceuticals” This review examined mechanisms regulating muscle repair, highlighting disruptions in aging and chronic diseases like Duchenne muscular dystrophy and diabetes. It noted that chronic inflammation and metabolic dysfunction hinder effective regeneration and discussed emerging therapies, suggesting multi-target approaches could be promising despite limited clinical evidence.
June 2026 in “Frontiers in Medicine” In this randomized controlled trial, daily use of a hair serum containing plant extracts and manganese PCA improved scalp tightness, reduced discomfort, and enhanced hair growth quality in men post-hair transplant, suggesting its efficacy as a dermocosmetic adjuvant for long-term hair care.
This study found that using a hair serum with specific plant-derived extracts and manganese PCA improved scalp condition and hair growth in men after hair transplantation compared to controls.
This review outlines current treatments for folliculitis decalvans and dissecting cellulitis of the scalp, noting conventional therapies' limitations and promising but limited results from targeted biologic agents.